Janone Inc. (NASDAQ:ALTS) Short Interest Down 37.3% in November

Janone Inc. (NASDAQ:ALTSGet Free Report) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 80,700 shares, a drop of 37.3% from the November 15th total of 128,800 shares. Based on an average daily volume of 178,800 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.6% of the company’s stock are short sold.

Janone Price Performance

Shares of NASDAQ ALTS traded up $0.11 during trading on Friday, hitting $3.67. 163,319 shares of the company traded hands, compared to its average volume of 236,001. Janone has a fifty-two week low of $0.46 and a fifty-two week high of $5.26. The firm has a fifty day moving average of $2.41. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 1.96.

Janone Company Profile

(Get Free Report)

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.

Featured Articles

Receive News & Ratings for Janone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Janone and related companies with MarketBeat.com's FREE daily email newsletter.